Digene Will Achieve Strategic Goals Faster Through Qiagen Merger, CEO Says
This article was originally published in The Gray Sheet
Executive Summary
Human papillomavirus test maker Digene will expand its international presence and gain critical mass to help counter looming competition in the lucrative HPV test market by merging with Dutch molecular diagnostics firm Qiagen